Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. The company's purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Sandoz ambition is to be the world’s leading and most valued generics company. Sandoz broad portfolio of high-quality medicines covers all major therapeutic areas.